Detalhe da pesquisa
1.
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Front Immunol
; 13: 1050250, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713447
2.
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy.
Mol Ther Oncolytics
; 14: 246-252, 2019 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31428674